ERBB2 and neoplasm: To overcome these challenges, further studies have been initiated aiming to investigate the upstream and downstream regulatory mechanisms of the Wnt/β-catenin signaling pathway and its potential crosstalk with the HER2 signaling axis, as well as the cellular heterogeneity within the IMPC tumor microenvironment to deepen our understanding of the molecular basis of IMPC resistance.